Targeted Next‐Generation Sequencing of the Leptin‐Melanocortin Pathway in Severe Obesity
Obesity · 2026
DOI: 10.1002/oby.70107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity, 2026. Verfasst von Nathan Faccioli und 12 weiteren Autor:innen. Beteiligte Einrichtung: AP-HP, Trousseau Hospital, Department of Pediatric Nutrition and Gastroenterology, Reference Center for Rare Diseases PRADORT (Prader-Willi Syndrome …. Hauptthemen laut MEDLINE: Leptin, Obesity, Morbid, Melanocortins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: French Pediatric Society (Société Française de Pédiatrie) cofounded by Novo Nordisk Laboratory, Société Française de Pédiatrie.
Abstract (Originalsprache)
Objective
Pathogenic variants in five established leptin‐melanocortin pathway genes ( LEP, LEPR, MC4R, PCSK1 , POMC ) are associated with severe early‐onset obesity and are targets for emerging treatments. However, these variants are rare in these patients, suggesting the involvement of additional genes interacting with this pathway.
Methods
Next‐generation sequencing (NGS) analysis was performed in 395 patients with severe obesity, including 213 children (mean BMI: 56.3 kg/m 2 ; BMI‐ z ‐score: 4.6). The analysis targeted 20 genes, including the 5 established genes. Rare genetic variants were assessed for pathogenicity using prediction algorithms, genetic databases, and literature review. Phenotypic data were retrospectively collected, focusing on obesity severity, age of onset, familial history, eating behavior disorder, neurodevelopmental and endocrine‐associated diseases, and obesity complications.
Results
Pathogenic heterozygous variants were identified in 34 patients (8.6%), 18 of them harboring pathogenic variants in the 15 additional genes. In adults, early‐onset obesity was more frequent in potentially pathogenic variants carriers than in non‐carriers (83.3% vs. 55.0%, p = 0.04). No differences were observed in the other phenotypic characteristics.
Conclusions
This supports the relevance of expanded genetic testing in severe obesity. Early‐onset obesity remains a key clinical feature to guide genetic investigation and identify patients who may benefit from early personalized care and targeted treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- AP-HP, Trousseau Hospital, Department of Pediatric Nutrition and Gastroenterology, Reference Center for Rare Diseases PRADORT (Prader-Willi Syndrome and Other Rare Forms of Obesity With Eating Behavior Disorders), Sorbo…
- INSERM, Nutrition and Obesity: Systemic Approaches, NutriOmics Research Unit, Sorbonne University, Paris, France.
- AP-HP, Pitie-Salpetriere Hospital, Nutrition Department, Reference Center for Rare Diseases (PRADORT, Prader-Willi Syndrome and Other Rare Forms of Obesity With Eating Behavior Disorders), Sorbonne University, Paris, Fr…
- AP-HP, Pitie-Salpetriere Hospital, Functional Unit for the Genetics of Obesity and Dyslipidemia, Endocrine and Oncology Biochemistry Department, Sorbonne University, Paris, France.
- Department of Pediatric Endocrinology and Diabetology, Reference Center for Growth and Development Endocrine Diseases, University Paris Cite, AP-HP, Robert Debre University Hospital, Paris, France.
- AP-HP, Georges Pompidou European Hospital, Department of Nutrition, Specialized Obesity Centre & INSERM UMRS 1149, University Paris Cite, Paris, France.
ORCID-Profile: Nathan Faccioli, Claire Carette, Blandine Gatta-Cherifi
Förderung
- French Pediatric Society (Société Française de Pédiatrie) cofounded by Novo Nordisk Laboratory
- Société Française de Pédiatrie
Zitieren
APA
Faccioli, N., Poitou, C., Georget, M., Bertin, F., Azar-Kolakez, A., Carette, C., Faucher, P., Gatta-Cherifi, B., Gonneau-Lejeune, J., Linglart, A., Clément, K., Le Beyec‐Le Bihan, J., & Dubern, B. (2026). Targeted Next‐Generation Sequencing of the Leptin‐Melanocortin Pathway in Severe Obesity. Obesity. https://doi.org/10.1002/oby.70107
Vancouver
Faccioli N, Poitou C, Georget M, Bertin F, Azar-Kolakez A, Carette C, et al. Targeted Next‐Generation Sequencing of the Leptin‐Melanocortin Pathway in Severe Obesity. Obesity. 2026. doi:10.1002/oby.70107
BibTeX
@article{Faccioli2026,
author = {Faccioli, Nathan and Poitou, Chrisitne and Georget, Mathieu and Bertin, Françoise and Azar-Kolakez, Ahlam and Carette, Claire and Faucher, Pauline and Gatta-Cherifi, Blandine and Gonneau-Lejeune, Julie and Linglart, Agnès and Clément, Karine and Le Beyec‐Le Bihan, Johanne and Dubern, Béatrice},
title = {Targeted Next‐Generation Sequencing of the Leptin‐Melanocortin Pathway in Severe Obesity},
journal = {Obesity},
year = {2026},
doi = {10.1002/oby.70107}
}
EUVIMED